-
1 Comment
Realcan Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 11.5% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Realcan Pharmaceutical Group Co., Ltd's total revenue sank by 13.4% to $7B since the same quarter in the previous year.
Its net income has increased by 96.9% to $-47M since the same quarter in the previous year.
Finally, its free cash flow grew by 109.2% to $20M since the same quarter in the previous year.
Based on the above factors, Realcan Pharmaceutical Group Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE1000013X5 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Beta | 0.4 |
|---|---|
| Dividend Yield | 0.7% |
| Market Cap | 4B |
| PE Ratio | 297.0 |
| Target Price | 15.15 |
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. The company operates in Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine segments. It sells drugs and medical devices. The company also provides medical logistics services; third-party logistics services; health service platform; and disinfection and sterilization. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002589.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
